Is chlormethiazole neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 4, 1997, Pages 737-745

  Thaminy, Seddik ^a   Reymann, Jean Michel ^a   Heresbach, Nathalie ^b   Allain, Hervé ^a   Lechat, Paul ^c   Bentué Ferrer, Danièle ^a  

^a Ave Pr Leon B   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c Academie des Sciences   (France)

Author keywords

aminergic neurotransmitters; cerebral ischemia; chlormethiazole; learning; memory; neuroprotection

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ANTICONVULSIVE AGENT; CLOMETHIAZOLE; DOPAMINE; HOMOVANILLIC ACID; NEUROTRANSMITTER; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROCHEMICAL DETECTION; ENTORHINAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MICRODIALYSIS; MONOAMINE METABOLISM; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN ISCHEMIA; CHLORMETHIAZOLE; CORPUS STRIATUM; DOPAMINE; EXTRACELLULAR SPACE; HIPPOCAMPUS; MALE; MAZE LEARNING; MICRODIALYSIS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

ANIMALIA;

EID: 0030937780     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00517-5     Document Type: Article

References (68)

1. Albers G. W. Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Clin. Neuropharmacol. 13:1990;177.
2. Baldwin H. A., Golado M. I., Murray T. K., De Souza R. J., Green A. R. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. Br. J. Pharmacol. 108:1993;590.
3. Barnes C. A. Spatial learning and memory process. The search for their neurobiological mechanisms in the rat Trends Neurosci. 11:1988;163.
4. Bentué-Ferrer D., Bellissant E., Decombe R., Allain H. Temporal profile of aminergic neurotransmitter release in striatal dialysates in rat with postischemic seizures. Exp. Brain Res. 97:1994;437.
5. Bentué-Ferrer D., Decombe R., Allain H. Pharmacologie de l'ischémie cérébrale. Sem. Hôp. Paris. 66:1990;2391.
6. Benveniste H., Drejer J., Schousboe A., Diemer N. H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369.
7. Bhardwaj A., Brannan T., Martinez-Tica J., Weinberger J. Ischemia in the dorsal hippocampus is associated with acute extracellular release of dopamine and norepinephrine. J. Neural Transm. (Gen. Sect.). 80:1990;195.
8. Bhardwaj A., Brannan T., Weinberger J. Pentobarbital inhibits extracellular release of dopamine in the ischemic striatum. J. Neural Transm. (Gen. Sect.). 82:1990;111.
9. Charonnat R., Lechat P., Chareton J. Sur les propriétés pharmacodynamiques d'un dérivé thiazolique (première note). Thérapie. 12:1957;68.
10. Charonnat R., Lechat P., Chareton J. Sur les propriétés pharmacodynamiques d'un dérivé thiazolique (3e note). Action sur le système nerveux central Thérapie. 13:1958;1.
11. Choi D. W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261.
12. Clemens J. A., Phebus L. A. Dopamine depletion protects striatal neurons from ischemia induced cell death. Life Sci. 42:1988;707.
13. Colado M. I., Murray T. K., Green A. R. 5-HT loss in rat brain following 3,4-methylenedioxy-methamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br. J. Pharmacol. 108:1993;583.
14. Cross A. J., Jones J. A., Baldwin H. A., Green A. R. Neuroprotective activity of chlormethiazole following transient forebrain ischemia in the gerbil. Br. J. Pharmacol. 104:1991;406.
15. Cross A. J., Jones J. A., Snares M., Jostell K. G., Bredberg U., Green A. R. The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. Br. J. Pharmacol. 114:1995;1625.
16. Cross A. J., Snape M. F., Green A. R. Chlormethiazole antagonises seizures induced by N-methyl-DL-aspartate without interacting with the NMDA receptor complex. Psychopharmacology. 112:1993;403.
17. A-receptor complex in rat brain. Br. J. Pharmacol. 98:1989;284.
18. Damsma G., Boisvert D. P., Mudrick L. A., Wenkstern D., Fibiger G. C. Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin and their metabolites in the rat striatum as determined by in vivo microdialysis. J. Neurochem. 54:1990;801.
19. Drejer J., Benveniste H., Diemer N. H., Schousboe A. Cellular origin of ischemia induced glutamate release from brain tissue in vivo and in vitro. J. Neurochem. 45:1985;145.
20. Filloux F., Townsend J. Pre and post-synaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 119:1993;79.
21. Ginsberg M., Busto R. Rodent models of cerebral ischemia. Stroke. 20:1989;1627.
22. Globus M. Y. T., Busto R., Dietrich W. D., Martinez E., Valdes I., Ginsberg M. D. Direct evidence for acute massive norepinephrine release in the hippocampus during transient ischemia. J. Cereb. Blood Flow Metab. 9:1989;892.
23. Globus M. Y. T., Ginsberg M. D., Dietrich W. D., Busto R., Scheinberg P. Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci. Lett. 80:1987;251.
24. Globus M. Y. T., Wester P., Busto R., Dietrich W. D. Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats. Stroke. 23:1992;1595.
25. Goodrick C. L. Learning, retention, and extention of a complex maze habit for mature young and senescent Wistar albino rats. J. Gerontol. 23:1972;298.
26. Green A. R., Cross A. J. Attenuation by chlormethiazole of oedema following focal ischaemia in the cerebral cortex of the rat. Neurosci. Lett. 173:1994;27.
27. Green A. R., Cross A. J. The neuroprotective actions of chlormethiazole. Prog. Neurobiol. 44:1994;463.
28. Green A. R., De Souza R. J., Williams J. L., Murray T. K., Cross A. J. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain, evidence for the protective effect of chlormethiazole. Neuropharmacology. 31:1992;315.
29. Gustafson I., Westerberg E. J., Weiloch T. Extracellular brain cortical levels of noradrenaline in ischemia. Effects of desipramine and postichemic administration of idazoxan Exp. Brain Res. 86:1991;555.
30. Hagberg H., Hellmanns A., Sandberg M., Wystrom B., Jacobson I., Hamberger A. Ischaemia-induced shift of inhibitory and excitatory amino acids from intra to extracellular compartments. J. Cereb. Blood Flow Metab. 5:1985;413.
31. A and glycine receptors by chlormethiazole. Eur. J. Pharmacol. 210:1992;239.
32. Hara H., Sukamoto T., Kogure K. Mechanism and pathogenesis of ischemia-induced neuronal damage. Prog. Neurobiol. 40:1993;645.
33. Hashimoto N., Matsumoto T., Mabe H., Hashitani T., Nishino H. Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum. Brain Res. Bull. 33:1993;281.
34. Hewitt K. E., Green A. R. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA (Ecstasy) to rats. Neuropharmacology. 33:1994;1589.
35. Iwasaki K., Kitamura Y., Ohgami Y., Mishima K., Fujiwara M. The disruption of spatial cognition and changes in brain amino acid, monoamine and acetylcholine in rats with transient cerebral ischemia. Brain Res. 709:1996;163.
36. Joseph R., Tsering C., Grunfeld S., Welch K. M. A. Serotonin may have neurotoxic properties. Neurosci. Lett. 136:1992;15.
37. Krause G. S., White B. C., Aust S. D., Nayini N. R., Kumar K. Brain cell death following ischemia and reperfusion, a proposed biochemical sequence. Crit. Care Med. 16:1988;714.
38. MacCulloch J. Excitatory aminoacid antagonists and their potential for the treatment of ischemic brain damage in man. Br. J. Clin. Pharmacol. 34:1992;106.
39. MacMillen B. A. CNS stimulants. Two distinct mechanisms of action for amphetamine-like drugs Trends Pharmacol. Sci. 4:1983;429.
40. Majumdar S. K. Chlormethiazole. Current status in the treatment of the acute ethanol withdrawal syndrome Drug Alcohol Depend. 27:1991;201.
41. Martin R. L., Lloyd H. G. E., Cowan A. I. The early events of oxygen and glucose deprivation. Setting the scene for neuronal death Trends Neurosci. 17:1994;251.
42. Meldrum B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:1990;27.
43. Moody E. J., Skolnick P. Chlormethiazole. Neurochemical actions at the γ-aminobutyric acid receptor complex Eur. J. Pharmacol. 164:1989;153.
44. Nunn J. A., Lepeillet E., Netto C. A., Hodges H., Gray J. A., Meldrum B. S. Global ischaemia. Hippocampal pathology and spatial deficits in the water maze Behav. Brain Res. 62:1994;41.
45. Obrenovitch T. P., Richards D. A. Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc. Brain Metab. Rev. 7:1995;1.
46. Obrenovitch T. P., Sarna G. S., Matsumoto T., Symon L. Extracellular striatal dopamine and its metabolites during transient cerebral ischemia. J. Neurochem. 54:1990;1526.
47. Ogren S. O. Chlormethiazole - Mode of action. Acta Psychiatr. Scand. 73(suppl. 329):1986;13.
48. Olton D. S., Papas B. C. Spatial memory and hippocampal function. Neuropsychologia. 17:1979;669.
49. Ooboshi H., Sadoshima S., Ibayashi S., Yao H., Uchimura H., Fujishima M. Isradipine attenuates the ischemia induced release of dopamine in the striatum of the rat. Eur. J. Pharmacol. 233:1993;165.
50. Ooboshi H., Sadoshima S., Yao H., Nakahara T., Uchimura H., Fujishima M. Inhibition of ischemia-induced dopamine release by ω-conotoxin, a calcium channel blocker, in the striatum of spontaneously hypertensive rats, in vivo brain dialysis study. J. Neurochem. 58:1992;298.
51. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;Academic Press, Sydney.
52. Peruche B., Krieglstein J. Mechanisms of drug actions against neuronal damage caused by ischemia - An overview. Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:1993;21.
53. Phebus L. A., Clemens J. A. Effects of transient global cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci. 44:1989;1335.
54. Pulsinelli W. A., Brierley J. B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 10:1979;267.
55. Pulsinelli W. A., Brierley J. B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491.
56. Rudolphi K. A., Schubert P., Parkinson F. E., Fredholm B. B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13:1992;439.
57. Schmidt C. J., Ritter J. K., Sonsalla P. K., Hamson G. R., Gibb J. W. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233:1985;539.
58. Snape M. F., Baldwin H. A., Cross A. J., Green A. R. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischemia in the rat. Neuroscience. 53:1993;837.
59. Snape M. F., Colado M. I., Green A. R. Chlormethiazole and dizocilpine block the behavioural, but not the neurotoxic effects of 5,7-dihydroxytryptamine in mice. Pharmacol. Toxicol. 74:1994;40.
60. Spetzler R. F., Hadley M. N. Protection against cerebral ischemia. The role of barbiturate Cerebrovasc. Brain Metab. Rev. 1:1989;212.
61. Sydserff S. G., Cross A. J., West K. J., Green A. R. The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia. Br. J. Pharmacol. 114:1995;1631.
62. Szatkowski M., Attwell D. Triggering and execution of neuronal death in brain ischaemia. Two phases of glutamate release by different mechanisms Trends Neurosci. 17:1994;359.
63. A-receptor complex in the central nervous system and in the anterior pituitary gland. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;397.
64. Volpe B. T., Davis H. P., Towle A., Dunlap W. P. Loss of hippocampal CA1 pyramidal neurons correlates with memory impairment in rats with ischemic or neurotoxin lesions. Behav. Neurosci. 106:1992;457.
65. Volpe B. T., Pulsinelli W. A., Tribuna O., Davis H. P. Behavioral performance of rats following transient forebrain ischemia. Stroke. 15:1984;558.
66. Wallman-Johansson A., Fredholm B. B. Release of adenosine and other purines from hippocampal slices stimulated electrically or by hypoxia/hypoglycemia effect of chlormethiazole. Life Sci. 55:1994;721.
67. Weihmuller F. B., O'Dell S. J., Marshall J. F. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse. 11:1992;155.
68. Wood E. R., Mumby D. G., Pinel J. P., Phillips A. G. Impaired object recognition memory in rats following ischemia-induced damage to the hippocampus. Behav. Neurosci. 107:1993;51.